Invention Grant
![Furo[3,4-b]pyrrole-containing BTK inhibitor](/docs/US/2024-02-06/US11891405B2/abs.jpg.600x600.jpg)
- Patent Title: Furo[3,4-b]pyrrole-containing BTK inhibitor
-
Application No.: US17276025Application Date: 2019-09-12
-
Publication No.: US11891405B2Publication Date: 2024-02-06
- Inventor: Yinsheng Zhang , Hongjiang Xu , Jing Ren , Qinglin Wang , Zheyang Wu , Chao Jin , Wei Shi , Xiaojin Wang , Xiangyi He , Xiayun Chang , Jie Wang , Tianxiao Zhao
- Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
- Applicant Address: CN Lianyungang
- Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
- Current Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
- Current Assignee Address: CN Jiangsu
- Agency: Fish & Richardson P.C.
- Priority: CN 1811072116.0 2018.09.14
- International Application: PCT/CN2019/105584 2019.09.12
- International Announcement: WO2020/052628A 2020.03.19
- Date entered country: 2021-03-12
- Main IPC: C07D519/00
- IPC: C07D519/00
![Furo[3,4-b]pyrrole-containing BTK inhibitor](/abs-image/US/2024/02/06/US11891405B2/abs.jpg.150x150.jpg)
Abstract:
The present application belongs to the field of pharmaceutical chemistry, and relates to a furo[3,4-b]pyrrole-containing BTK inhibitor, and in particular, to a compound of formula (I), a stereisomer or pharmacologically acceptable salt thereof, a preparation method therefor, a pharmaceutical composition containing the compound, and use thereof in treating BTK-related diseases.
Public/Granted literature
- US20220033419A1 FURO[3,4-B]PYRROLE-CONTAINING BTK INHIBITOR Public/Granted day:2022-02-03
Information query
